{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:39:08Z","timestamp":1775554748331,"version":"3.50.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Sinai University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s40262-025-01560-x","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T14:01:58Z","timestamp":1756476118000},"page":"1655-1668","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of Preliminary Bronchodilation Effect on Aerosol Delivery from a Dry Powder Inhaler for Patients with Chronic Obstructive Pulmonary Disease with Suboptimal Peak Inspiratory Flow Rate"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6526-2925","authenticated-orcid":false,"given":"Mohamed Ismail","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabila Ibrahim","family":"Laz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin M.","family":"Madney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed E. A.","family":"Abdelrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadeer S.","family":"Harb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"1560_CR1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.rmed.2016.07.013","volume":"118","author":"P Haidl","year":"2016","unstructured":"Haidl P, Heindl S, Siemon K, Bernacka M, Cloes RM. Inhalation device requirements for patients\u2019 inhalation maneuvers. Respir Med. 2016;118:65\u201375.","journal-title":"Respir Med"},{"issue":"1","key":"1560_CR2","first-page":"34","volume":"1","author":"M Alagusundaram","year":"2010","unstructured":"Alagusundaram M, Deepthi N, Ramkanth S, Angalaparameswari S, Saleem TM, Gnanaprakash K, et al. Dry powder inhalers-An overview. Int J Pharm Sci Res. 2010;1(1):34\u201342.","journal-title":"Int J Pharm Sci Res"},{"issue":"3","key":"1560_CR3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1742-1241.2011.02832.x","volume":"66","author":"H Chrystyn","year":"2012","unstructured":"Chrystyn H, Niederlaender C. The Genuair\u00ae inhaler: a novel, multidose dry powder inhaler. Int J Clin Pract. 2012;66(3):309\u201317.","journal-title":"Int J Clin Pract"},{"issue":"6","key":"1560_CR4","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.1742-1241.2007.01382.x","volume":"61","author":"H Chrystyn","year":"2007","unstructured":"Chrystyn H. The DiskusTM: a review of its position among dry powder inhaler devices. Int J Clin Pract. 2007;61(6):1022\u201336.","journal-title":"Int J Clin Pract"},{"issue":"6","key":"1560_CR5","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.rmed.2011.01.005","volume":"105","author":"AS Melani","year":"2011","unstructured":"Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105(6):930\u20138.","journal-title":"Respir Med"},{"key":"1560_CR6","doi-asserted-by":"crossref","unstructured":"Laube BL, Janssens HM, de Jongh FH, Devadason SG, Dhand R, Diot P, et al. What the pulmonary specialist should know about the new inhalation therapies. European Respiratory Society; 2011.","DOI":"10.1183\/09031936.00166410"},{"issue":"11","key":"1560_CR7","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.rmed.2007.06.008","volume":"101","author":"RA Al-Showair","year":"2007","unstructured":"Al-Showair RA, Tarsin WY, Assi KH, Pearson SB, Chrystyn H. Can all patients with COPD use the correct inhalation flow with all inhalers and does training help? Respir Med. 2007;101(11):2395\u2013401.","journal-title":"Respir Med"},{"issue":"12","key":"1560_CR8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/psb.529","volume":"20","author":"H Chrystyn","year":"2009","unstructured":"Chrystyn H, Price D. What you need to know about inhalers and how to use them. Prescriber. 2009;20(12):47\u201352.","journal-title":"Prescriber"},{"key":"1560_CR9","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S195438","author":"S Ghosh","year":"2019","unstructured":"Ghosh S, Pleasants RA, Ohar JA, Donohue JF, Drummond MB. Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD. Int J Chron Obstruct Pulmon Dis. 2019. https:\/\/doi.org\/10.2147\/COPD.S195438.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"1560_CR10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4104\/pcrj.2011.00062","volume":"20","author":"M EAC Broeders","year":"2011","unstructured":"EAC Broeders M, Vincken W, Corbetta L. The ADMIT series\u2014issues in inhalation therapy. 7) Ways to improve pharmacological management of COPD: the importance of inhaler choice and inhalation technique. Prim Care Respir J. 2011;20(3):338\u201343.","journal-title":"Prim Care Respir J"},{"issue":"5","key":"1560_CR11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/1715163516660573","volume":"149","author":"S Dougall","year":"2016","unstructured":"Dougall S, Bolt J, Semchuk W, Winkel T. Inhaler assessment in COPD patients: a primer for pharmacists. Can Pharm J. 2016;149(5):268\u201373.","journal-title":"Can Pharm J"},{"issue":"3","key":"1560_CR12","volume":"75","author":"AM Ali","year":"2021","unstructured":"Ali AM, Zawbaa HM, Sayed OM, Harb HS, Saeed H, Boshra MS, et al. In vitro and in vivo performance modelling and optimisation of different dry powder inhalers: a complementary study of neural networks, genetic algorithms and decision trees. Int J Clin Pract. 2021;75(3): e13764.","journal-title":"Int J Clin Pract"},{"issue":"6","key":"1560_CR13","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14077","volume":"75","author":"MA Abdelrahman","year":"2021","unstructured":"Abdelrahman MA, Saeed H, Osama H, Harb HS, Madney YM, Abdelrahim ME. Effect of verbal counselling on metred-dose inhaler proper use and lung function test amongst asthmatic patients: a meta-analysis. Int J Clin Pract. 2021;75(6): e14077.","journal-title":"Int J Clin Pract"},{"issue":"6","key":"1560_CR14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/jamp.2017.1416","volume":"30","author":"S Ghosh","year":"2017","unstructured":"Ghosh S, Ohar JA, Drummond MB. Peak inspiratory flow rate in chronic obstructive pulmonary disease: implications for dry powder inhalers. J Aerosol Med Pulm Drug Deliv. 2017;30(6):381\u20137.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"1560_CR15","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S32674","author":"BP Yawn","year":"2012","unstructured":"Yawn BP, Colice GL, Hodder R. Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting. Int J Chron Obstruct Pulmon Dis. 2012. https:\/\/doi.org\/10.2147\/COPD.S32674.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"4","key":"1560_CR16","volume":"75","author":"HS Harb","year":"2021","unstructured":"Harb HS, Ibrahim Laz N, Rabea H, Abdelrahim ME. Real-life assessment of chronic obstructive pulmonary disease patient performance with different inhalers. Int J Clin Pract. 2021;75(4): e13905.","journal-title":"Int J Clin Pract"},{"key":"1560_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-017-0698-3","volume":"19","author":"OS Usmani","year":"2018","unstructured":"Usmani OS, Lavorini F, Marshall J, Dunlop WCN, Heron L, Farrington E, et al. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir Res. 2018;19:1\u201320.","journal-title":"Respir Res"},{"key":"1560_CR18","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01794-2016","author":"M Molimard","year":"2017","unstructured":"Molimard M, Raherison C, Lignot S, Balestra A, Lamarque S, Chartier A, et al. Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients. Eur Respir J. 2017. https:\/\/doi.org\/10.1183\/13993003.01794-2016.","journal-title":"Eur Respir J"},{"key":"1560_CR19","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1590\/S1806-37132009000900002","volume":"35","author":"MLdM Souza","year":"2009","unstructured":"Souza MLdM, Meneghini AC, Vianna EO, Borges MC. Knowledge of and technique for using inhalation devices among asthma patients and COPD patients. J Bras Pneumol. 2009;35:824\u201331.","journal-title":"J Bras Pneumol"},{"issue":"6","key":"1560_CR20","volume":"75","author":"HS Harb","year":"2021","unstructured":"Harb HS, Ibrahim Laz N, Rabea H, Abdelrahim ME. Determinants of incorrect inhaler technique in chronic obstructive pulmonary disease patients. Int J Clin Pract. 2021;75(6): e14073.","journal-title":"Int J Clin Pract"},{"issue":"7","key":"1560_CR21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/01902148.2020.1789903","volume":"46","author":"HS Harb","year":"2020","unstructured":"Harb HS, Laz NI, Rabea H, Abdelrahim ME. First-time handling of different inhalers by chronic obstructive lung disease patients. Exp Lung Res. 2020;46(7):258\u201369.","journal-title":"Exp Lung Res"},{"key":"1560_CR22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00044011-200020010-00004","volume":"20","author":"A Palander","year":"2000","unstructured":"Palander A, Mattila T, Karhu M, Muttonen E. In vitro comparison of three salbutamol-containing multidose dry powder inhalers: Buventol Easyhaler\u00ae, Inspiryl Turbuhaler\u00ae and Ventoline Diskus\u00ae. Clin Drug Investig. 2000;20:25\u201333.","journal-title":"Clin Drug Investig"},{"key":"1560_CR23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12247-014-9171-8","volume":"9","author":"AMA Ali","year":"2014","unstructured":"Ali AMA, Abdelrahim MEA. Modeling and optimization of terbutaline emitted from a dry powder inhaler and influence on systemic bioavailability using data mining technology. J Pharm Innov. 2014;9:38\u201347.","journal-title":"J Pharm Innov"},{"issue":"5","key":"1560_CR24","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1183\/13993003\/erj.18.5.780","volume":"18","author":"M Broeders","year":"2001","unstructured":"Broeders M, Molema J, Vermue N, Folgering HTM. Peak inspiratory flow rate and slope of the inhalation profiles in dry powder inhalers. Eur Respir J. 2001;18(5):780\u20133.","journal-title":"Eur Respir J"},{"issue":"5","key":"1560_CR25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/ppul.20180","volume":"39","author":"I Amirav","year":"2005","unstructured":"Amirav I, Newhouse MT, Mansour Y. Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma. Pediatr Pulmonol. 2005;39(5):447\u201351.","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"1560_CR26","first-page":"1103","volume":"14","author":"DA Mahler","year":"2017","unstructured":"Mahler DA. Peak inspiratory flow rate as a criterion for dry powder inhaler use in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2017;14(7):1103\u20137.","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"1560_CR27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/thx.32.2.194","volume":"32","author":"D Pavia","year":"1977","unstructured":"Pavia D, Thomson ML, Clarke SW, Shannon HS. Effect of lung function and mode of inhalation on penetration of aerosol into the human lung. Thorax. 1977;32(2):194\u20137.","journal-title":"Thorax"},{"issue":"6","key":"1560_CR28","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1164\/ajrccm\/136.6.1445","volume":"136","author":"JS Ilowite","year":"1987","unstructured":"Ilowite JS, Gorvoy JD, Smaldone GC. Quantitative deposition of aerosolized gentamicin in cystic fibrosis1-3. Am Rev Respir Dis. 1987;136(6):1445\u20139.","journal-title":"Am Rev Respir Dis"},{"key":"1560_CR29","unstructured":"Dolovich M, Nahmias C, Coates G. Unleashing the PET: 3D imaging of the lung. In: Byron PR, Dalby R, Farr SJ, editors. Respiratory Drug Delivery VII. Raleigh, NC: Serentec Press; 2000. p. 215\u201330."},{"issue":"6","key":"1560_CR30","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","volume":"56","author":"NR Labiris","year":"2003","unstructured":"Labiris NR, Dolovich MB. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. 2003;56(6):588\u201399.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"1560_CR31","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1038\/s41598-020-64235-6","volume":"10","author":"S-Y Chen","year":"2020","unstructured":"Chen S-Y, Huang C-K, Peng H-C, Yu C-J, Chien J-Y. Inappropriate peak inspiratory flow rate with dry powder inhaler in chronic obstructive pulmonary disease. Sci Rep. 2020;10(1):7271.","journal-title":"Sci Rep"},{"key":"1560_CR32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jddst.2017.05.022","volume":"40","author":"HS Harb","year":"2017","unstructured":"Harb HS, Elberry AA, Rabea H, Fathy M, Abdelrahim ME. Is combihaler usable for aerosol delivery in single limb non-invasive mechanical ventilation? J Drug Deliv Sci Technol. 2017;40:28\u201334.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"11","key":"1560_CR33","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.4187\/respcare.05976","volume":"63","author":"HS Harb","year":"2018","unstructured":"Harb HS, Elberry AA, Rabea H, Fathy M, Abdelrahim ME. Performance of large spacer versus nebulizer T-piece in single-limb noninvasive ventilation. Respir Care. 2018;63(11):1360\u20139.","journal-title":"Respir Care"},{"key":"1560_CR34","doi-asserted-by":"crossref","unstructured":"Sanders MJ. Guiding inspiratory flow: development of the in-check DIAL G16, a tool for improving inhaler technique. Pulm Med. 2017;2017:1495867.","DOI":"10.1155\/2017\/1495867"},{"issue":"4","key":"1560_CR35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2125.1992.tb05921.x","volume":"34","author":"M Hindle","year":"1992","unstructured":"Hindle M, Chrystyn H. Determination of the relative bioavailability of salbutamol to the lung following inhalation [see comments]. Br J Clin Pharmacol. 1992;34(4):311\u20135.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"1560_CR36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/089426802760292591","volume":"15","author":"V Silkstone","year":"2002","unstructured":"Silkstone V, Dennis J, Pieron C, Chrystyn H. An investigation of in vitro\/in vivo correlations for salbutamol nebulized by eight systems. J Aerosol Med. 2002;15(3):251\u20139.","journal-title":"J Aerosol Med"},{"key":"1560_CR37","doi-asserted-by":"crossref","first-page":"175346662211073","DOI":"10.1177\/17534666221107312","volume":"16","author":"B Huber","year":"2022","unstructured":"Huber B, Keller C, Jenkins M, Raza A, Aurivillius M. Effect of inhaled budesonide\/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flow. Ther Adv Respir Dis. 2022;16:17534666221107312.","journal-title":"Ther Adv Respir Dis"},{"issue":"2","key":"1560_CR38","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(21)00561-0","volume":"10","author":"P Venkatesan","year":"2022","unstructured":"Venkatesan P. GOLD report: 2022 update. Lancet Respir Med. 2022;10(2): e20.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"1560_CR39","first-page":"13","volume":"20","author":"AL Coates","year":"2013","unstructured":"Coates AL, Graham BL, McFadden RG, McParland C, Moosa D, Provencher S, et al. Spirometry in primary care. Can Respir J. 2013;20(1):13.","journal-title":"Can Respir J"},{"issue":"1","key":"1560_CR40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/01902148.2017.1282993","volume":"43","author":"A Hassan","year":"2017","unstructured":"Hassan A, Salah Eldin R, Abdelrahman MM, Abdelrahim ME. In-vitro\/in-vivo comparison of inhaled salbutamol dose delivered by jet nebulizer, vibrating mesh nebulizer and metered dose inhaler with spacer during non-invasive ventilation. Exp Lung Res. 2017;43(1):19\u201328.","journal-title":"Exp Lung Res"},{"issue":"5","key":"1560_CR41","doi-asserted-by":"crossref","first-page":"1900164","DOI":"10.1183\/13993003.00164-2019","volume":"53","author":"D Singh","year":"2019","unstructured":"Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164.","journal-title":"Eur Respir J"},{"issue":"6","key":"1560_CR42","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.hrtlng.2017.08.004","volume":"46","author":"IO Moustafa","year":"2017","unstructured":"Moustafa IO, Ali MR-A, Al Hallag M, Rabea H, Fink JB, Dailey P, et al. Lung deposition and systemic bioavailability of different aerosol devices with and without humidification in mechanically ventilated patients. Heart Lung. 2017;46(6):464\u20137.","journal-title":"Heart Lung"},{"issue":"7","key":"1560_CR43","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3109\/10837450.2015.1116567","volume":"22","author":"RR Hussein","year":"2017","unstructured":"Hussein RR, Ali MAA, Salem HF, Abdelrahman MM, Said AS, Abdelrahim ME. In vitro\/in vivo correlation and modeling of emitted dose and lung deposition of inhaled salbutamol from metered dose inhalers with different types of spacers in noninvasively ventilated patients. Pharm Dev Technol. 2017;22(7):871\u201380.","journal-title":"Pharm Dev Technol"},{"key":"1560_CR44","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejps.2016.11.018","volume":"97","author":"H Rabea","year":"2017","unstructured":"Rabea H, Ali AM, Eldin RS, Abdelrahman MM, Said AS, Abdelrahim ME. Modelling of in-vitro and in-vivo performance of aerosol emitted from different vibrating mesh nebulisers in non-invasive ventilation circuit. Eur J Pharm Sci. 2017;97:182\u201391.","journal-title":"Eur J Pharm Sci"},{"key":"1560_CR45","volume":"59","author":"HS Harb","year":"2020","unstructured":"Harb HS, Saeed H, Madney YM, Abdelrahman MA, Osama H, Esquinas AM, et al. Update efficacy of aerosol therapy with noninvasive ventilator approach (non-invasive ventilation and nasal high flow). J Drug Deliv Sci Technol. 2020;59: 101922.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1560_CR46","volume":"55","author":"YM Madney","year":"2020","unstructured":"Madney YM, Laz NI, Elberry AA, Rabea H, Abdelrahim ME. The influence of changing interfaces on aerosol delivery within high flow oxygen setting in adults: an in-vitro study. J Drug Deliv Sci Technol. 2020;55: 101365.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1560_CR47","doi-asserted-by":"crossref","first-page":"105298","DOI":"10.1016\/j.ejps.2020.105298","volume":"147","author":"HS Harb","year":"2020","unstructured":"Harb HS, Laz NI, Rabea H, Abdelrahim MEA. Prevalence and predictors of suboptimal peak inspiratory flow rate in COPD patients. Eur J Pharm Sci. 2020;147:105298.","journal-title":"Eur J Pharm Sci"},{"key":"1560_CR48","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2147\/COPD.S195438","volume":"14","author":"S Ghosh","year":"2019","unstructured":"Ghosh S, Pleasants RA, Ohar JA, Donohue JF, Drummond MB. Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD. Int J Chron Obstruct Pulmon Dis. 2019;14:585\u201395.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"1560_CR49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1089\/jamp.2012.0987","volume":"26","author":"DA Mahler","year":"2013","unstructured":"Mahler DA, Waterman LA, Gifford AH. Prevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus\u00ae dry powder inhaler. J Aerosol Med Pulm Drug Deliv. 2013;26(3):174\u20139.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"1560_CR50","doi-asserted-by":"crossref","unstructured":"Malmberg LP, Rytil\u00e4 P, Happonen P, Haahtela T. Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters. Int J Chron Obstr Pulm Dis. 2010;5:257\u201362.","DOI":"10.2147\/COPD.S11474"},{"issue":"3","key":"1560_CR51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/rmed.2003.1289","volume":"97","author":"J van der Palen","year":"2003","unstructured":"van der Palen J. Peak inspiratory flow through diskus and turbuhaler, measured by means of a peak inspiratory flow meter (In-Check DIAL\u00ae). Respir Med. 2003;97(3):285\u20139.","journal-title":"Respir Med"},{"issue":"3","key":"1560_CR52","first-page":"217","volume":"4","author":"G Sharma","year":"2017","unstructured":"Sharma G, Mahler DA, Mayorga VM, Deering KL, Harshaw Q, Ganapathy V. Prevalence of low peak inspiratory flow rate at discharge in patients hospitalized for COPD exacerbation. Chron Obstr Pulm Dis J COPD Found. 2017;4(3):217.","journal-title":"Chron Obstr Pulm Dis J COPD Found."},{"issue":"1","key":"1560_CR53","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13293-024-00609-z","volume":"15","author":"A Kautzky","year":"2024","unstructured":"Kautzky A, Nopp S, Gattinger D, Petrovic M, Antlinger M, Schomacker D, et al. Sex differences of post-Covid patients undergoing outpatient pulmonary rehabilitation. Biol Sex Differ. 2024;15(1):36.","journal-title":"Biol Sex Differ"},{"issue":"1","key":"1560_CR54","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/jwh.2022.0104","volume":"32","author":"L Spicuzza","year":"2023","unstructured":"Spicuzza L, Campisi R, Alia S, Prestifilippo S, Giuffrida ML, Angileri L, et al. Female sex affects respiratory function and exercise ability in patients recovered from COVID-19 pneumonia. J Womens Health. 2023;32(1):18\u201323.","journal-title":"J Womens Health"},{"key":"1560_CR55","first-page":"491","volume-title":"Smoking cessation in chronic obstructive pulmonary disease. Seminars in respiratory and critical care medicine","author":"DP Tashkin","year":"2015","unstructured":"Tashkin DP. Smoking cessation in chronic obstructive pulmonary disease. Seminars in respiratory and critical care medicine. New York: Thieme Medical Publishers; 2015. p. 491\u2013507."},{"issue":"8","key":"1560_CR56","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1513\/AnnalsATS.201611-903OC","volume":"14","author":"CH Loh","year":"2017","unstructured":"Loh CH, Peters SP, Lovings TM, Ohar JA. Suboptimal inspiratory flow rates are associated with chronic obstructive pulmonary disease and all-cause readmissions. Ann Am Thorac Soc. 2017;14(8):1305\u201311.","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"1560_CR57","first-page":"246","volume":"6","author":"AG Duarte","year":"2019","unstructured":"Duarte AG, Tung L, Zhang W, Hsu ES, Kuo Y-F, Sharma G. Spirometry measurement of peak inspiratory flow identifies suboptimal use of dry powder inhalers in ambulatory patients with COPD. Chron Obstr Pulm Dis J COPD Found. 2019;6(3):246.","journal-title":"Chron Obstr Pulm Dis J COPD Found."},{"issue":"1","key":"1560_CR58","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1183\/09031936.00024807","volume":"31","author":"W Janssens","year":"2008","unstructured":"Janssens W, VandenBrande P, Hardeman E, De Langhe E, Philps T, Troosters T, et al. Inspiratory flow rates at different levels of resistance in elderly COPD patients. Eur Respir J. 2008;31(1):78\u201383.","journal-title":"Eur Respir J"},{"issue":"1","key":"1560_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2193-1801-3-496","volume":"3","author":"JN Seheult","year":"2014","unstructured":"Seheult JN, Costello S, Tee KC, Bholah T, Al Bannai H, Sulaiman I, et al. Investigating the relationship between peak inspiratory flow rate and volume of inhalation from a Diskus\u2122 Inhaler and baseline spirometric parameters: a cross-sectional study. Springerplus. 2014;3(1):1\u20137.","journal-title":"Springerplus"},{"key":"1560_CR60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/JAA.S127580","volume":"10","author":"T Kawamatawong","year":"2017","unstructured":"Kawamatawong T, Khiawwan S, Pornsuriyasak P. Peak inspiratory flow rate measurement by using In-Check DIAL for the different inhaler devices in elderly with obstructive airway diseases. J Asthma Allergy. 2017;10:17\u201321.","journal-title":"J Asthma Allergy."},{"issue":"4","key":"1560_CR61","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0895-4356(00)00318-8","volume":"54","author":"RI Harik-Khan","year":"2001","unstructured":"Harik-Khan RI, Wise RA, Fleg JL. The effect of gender on the relationship between body fat distribution and lung function. J Clin Epidemiol. 2001;54(4):399\u2013406.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"1560_CR62","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1378\/chest.111.4.891","volume":"111","author":"R Lazarus","year":"1997","unstructured":"Lazarus R, Sparrow D, Weiss ST. Effects of obesity and fat distribution on ventilatory function: the normative aging study. Chest. 1997;111(4):891\u20138.","journal-title":"Chest"},{"issue":"5","key":"1560_CR63","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/joim.12949","volume":"286","author":"HJ Park","year":"2019","unstructured":"Park HJ, Cho JH, Kim HJ, Park JY, Lee HS, Byun MK. The effect of low body mass index on the development of chronic obstructive pulmonary disease and mortality. J Intern Med. 2019;286(5):573\u201382.","journal-title":"J Intern Med"},{"issue":"11","key":"1560_CR64","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1159\/000511022","volume":"99","author":"EK Kim","year":"2021","unstructured":"Kim EK, Singh D, Park JH, Park YB, Kim S-I, Park B, et al. Impact of body mass index change on the prognosis of chronic obstructive pulmonary disease. Respiration. 2021;99(11):943\u201353.","journal-title":"Respiration"},{"key":"1560_CR65","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S353441","author":"DA Mahler","year":"2022","unstructured":"Mahler DA, Niu X, Deering KL, Dembek C. Prospective evaluation of exacerbations associated with suboptimal peak inspiratory flow among stable outpatients with COPD. Int J Chron Obstr Pulm Dis. 2022. https:\/\/doi.org\/10.2147\/COPD.S353441.","journal-title":"Int J Chron Obstr Pulm Dis"},{"issue":"5","key":"1560_CR66","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1378\/chest.107.5.1298","volume":"107","author":"LC Collins","year":"1995","unstructured":"Collins LC, Hoberty PD, Walker JF, Fletcher EC, Peiris AN. The effect of body fat distribution on pulmonary function tests. Chest. 1995;107(5):1298\u2013302.","journal-title":"Chest"},{"issue":"6","key":"1560_CR67","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1089\/jamp.2015.1224","volume":"28","author":"D WdB Prime","year":"2015","unstructured":"WdB Prime D, Hamilton M, Cahn A, Preece A, Kelleher D, Baines A, Moore A, Brealey N, Moynihan J. Effect of disease severity in asthma and chronic obstructive pulmonary disease on inhaler-specific inhalation profiles through the ELLIPTA\u00ae dry powder inhaler. J Aerosol Med Pulm Drug Deliv. 2015;28(6):486\u201397.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"1560_CR68","doi-asserted-by":"crossref","unstructured":"Harb HS, Laz NI, Rabea H, Madney YM, Boshra MS, Abdelrahim ME. Aerosol drug-delivery and short-term clinical outcomes of suboptimal peak inspiratory flow rate in chronic obstructive pulmonary disease. Int J Clin Pract. 2021;75(12):e14845.","DOI":"10.1111\/ijcp.14845"},{"issue":"2","key":"1560_CR69","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3390\/biomedicines10020458","volume":"10","author":"MT Leving","year":"2022","unstructured":"Leving MT, Kocks J, Bosnic-Anticevich S, Dekhuijzen R, Usmani OS. Relationship between peak inspiratory flow and patient and disease characteristics in individuals with COPD\u2014a systematic scoping review. Biomedicines. 2022;10(2):458.","journal-title":"Biomedicines."},{"key":"1560_CR70","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S319511","author":"JA Ohar","year":"2022","unstructured":"Ohar JA, Ferguson GT, Mahler DA, Drummond MB, Dhand R, Pleasants RA, et al. Measuring peak inspiratory flow in patients with chronic obstructive pulmonary disease. Int J Chron Obstr Pulm Dis. 2022. https:\/\/doi.org\/10.2147\/COPD.S319511.","journal-title":"Int J Chron Obstr Pulm Dis"},{"issue":"1","key":"1560_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"S Chen","year":"2020","unstructured":"Chen S, Huang C, Peng H, Yu C, Chien J. Inappropriate peak inspiratory flow rate with dry powder inhaler in chronic obstructive pulmonary disease. Sci Rep. 2020;10(1):1\u20139.","journal-title":"Sci Rep"},{"issue":"2","key":"1560_CR72","first-page":"77","volume":"48","author":"YM Madney","year":"2022","unstructured":"Madney YM, Harb HS, Por\u00e9e T, Eckes M, Boules ME, Abdelrahim ME. Preliminary bronchodilator dose effect on aerosol-delivery through different nebulizers in noninvasively ventilated COPD patients. Exp Lung Res. 2022;48(2):77\u201385.","journal-title":"Exp Lung Res"},{"key":"1560_CR73","doi-asserted-by":"crossref","unstructured":"Leving MT, van Boven JF, Bosnic-Anticevich SZ, van Cooten J, Correia de Sousa J, Cvetkovski B, et al. Suboptimal peak inspiratory flow and critical inhalation errors are associated with higher COPD-related healthcare costs. Int J Chron Obstr Pulm Dis. 2022;17:2401\u201315.","DOI":"10.2147\/COPD.S380736"},{"issue":"12","key":"1560_CR74","volume":"75","author":"HS Harb","year":"2021","unstructured":"Harb HS, Ibrahim Laz N, Rabea H, Madney YM, Boshra MS, Abdelrahim ME. Aerosol drug-delivery and short-term clinical outcomes of suboptimal peak inspiratory flow rate in chronic obstructive pulmonary disease. Int J Clin Pract. 2021;75(12): e14845.","journal-title":"Int J Clin Pract"},{"issue":"4","key":"1560_CR75","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3109\/10837450.2011.620970","volume":"18","author":"M Abdelrahim","year":"2013","unstructured":"Abdelrahim M, Assi KH, Chrystyn H. Dose emission and aerodynamic characterization of the terbutaline sulphate dose emitted from a Turbuhaler at low inhalation flow. Pharm Dev Technol. 2013;18(4):944\u20139.","journal-title":"Pharm Dev Technol"},{"key":"1560_CR76","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/2193-1801-3-496","volume":"3","author":"J Seheult","year":"2014","unstructured":"Seheult J, Costello S, Tee K, Bholah T, Al Bannai H, Sulaiman I, et al. Investigating the relationship between peak inspiratory flow rate and volume of inhalation from a Diskus\u2122 inhaler and baseline spirometric parameters: a cross-sectional study. Springerplus. 2014;3:496.","journal-title":"Springerplus"},{"issue":"1","key":"1560_CR77","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/jam.1996.9.55","volume":"9","author":"SP Newman","year":"1996","unstructured":"Newman SP, Newhouse MT. Effect of add-on devices for aerosol drug delivery: deposition studies and clinical aspects. J Aerosol Med. 1996;9(1):55\u201370.","journal-title":"J Aerosol Med"},{"issue":"6","key":"1560_CR78","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/thx.49.6.549","volume":"49","author":"M Hindle","year":"1994","unstructured":"Hindle M, Chrystyn H. Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices. Thorax. 1994;49(6):549\u201353.","journal-title":"Thorax"},{"issue":"4","key":"1560_CR79","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-2125.2008.03195.x","volume":"66","author":"K B\u00f8nnelykke","year":"2008","unstructured":"B\u00f8nnelykke K, Jespersen JJ, Bisgaard H. Early bioavailability of inhaled salbutamol reflects lung dose in children. Br J Clin Pharmacol. 2008;66(4):562.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"1560_CR80","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2125.2002.01632.x","volume":"54","author":"V Silkstone","year":"2002","unstructured":"Silkstone V, Corlett S, Chrystyn H. Determination of the relative bioavailability of salbutamol to the lungs and systemic circulation following nebulization. Br J Clin Pharmacol. 2002;54(2):115\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"1560_CR81","volume-title":"Ther relationship betweeen peak inspiratory flow rate (PIFR) and COPD severity measured as FEV1% predicted, and other lung function parameters in 33304 tests in patients at two different sites in Karolinska University Hospital in Stockholm","author":"M Anderson","year":"2022","unstructured":"Anderson M, Sailer E, Bj\u00f6rk E, Gustafsson T. Ther relationship betweeen peak inspiratory flow rate (PIFR) and COPD severity measured as FEV1% predicted, and other lung function parameters in 33304 tests in patients at two different sites in Karolinska University Hospital in Stockholm. Stockholm: European Respiratory Society; 2022."},{"issue":"3\u20134","key":"1560_CR82","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/01902148.2019.1621408","volume":"45","author":"MS Boshra","year":"2019","unstructured":"Boshra MS, Almeldien AG, Eldin RS, Elberry AA, Abdelwahab NS, Salem MN, et al. Inhaled salbutamol from aerolizer and diskus at different inhalation flows, inhalation volume and number of inhalations in both healthy subjects and COPD patients. Exp Lung Res. 2019;45(3\u20134):84\u201391.","journal-title":"Exp Lung Res"},{"key":"1560_CR83","unstructured":"Abdelrahim M. Relative bioavailability of terbutaline to the lungs following inhalation using different methods. Ph.D. thesis, University of Bradford; 2009."},{"key":"1560_CR84","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s41030-015-0010-y","volume":"2","author":"A Hassan","year":"2016","unstructured":"Hassan A, Rabea H, Hussein RR, Salah Eldin R, Abdelrahman MM, Said AS, et al. In-vitro characterization of the aerosolized dose during non-invasive automatic continuous positive airway pressure ventilation. Pulm Ther. 2016;2:115\u201326.","journal-title":"Pulm Ther"},{"issue":"8","key":"1560_CR85","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.2042-7158.2010.01134.x","volume":"62","author":"ME Abdelrahim","year":"2010","unstructured":"Abdelrahim ME, Plant P, Chrystyn H. In-vitro characterisation of the nebulised dose during non-invasive ventilation. J Pharm Pharmacol. 2010;62(8):966\u201372.","journal-title":"J Pharm Pharmacol"},{"key":"1560_CR86","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jddst.2017.04.014","volume":"39","author":"YM Madney","year":"2017","unstructured":"Madney YM, Fathy M, Elberry AA, Rabea H, Abdelrahim ME. Nebulizers and spacers for aerosol delivery through adult nasal cannula at low oxygen flow rate: an in-vitro study. J Drug Deliv Sci Technol. 2017;39:260\u20135.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1560_CR87","volume":"61","author":"SM Seif","year":"2021","unstructured":"Seif SM, Elnady MA, Rabea H, Saeed H, Abdelrahim ME. Effect of different connection adapters on aerosol delivery in invasive ventilation setting; an in-vitro study. J Drug Deliv Sci Technol. 2021;61: 102177.","journal-title":"J Drug Deliv Sci Technol"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-025-01560-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-025-01560-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-025-01560-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T01:04:56Z","timestamp":1763168696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-025-01560-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":87,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1560"],"URL":"https:\/\/doi.org\/10.1007\/s40262-025-01560-x","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"3 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No external funding was used in the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Mohamed Ismail Hassan, Nabila Ibrahim Laz, Yasmin M. Madney, Mohamed E.A. Abdelrahim, and Hadeer S. Harb declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Mohamed Ismail Hassan (M.I.H.): conception, research, and writing; N.I.L.: conception, planning of study design, and copy editing; Y.M.M.: data entry, statistical analysis, and reviewing of results; M.E.A.A.: conception, planning of study design, and copy editing; H.S.H.: conception, planning of study design, and copy editing. All authors have read and agreed to the published version of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"The study was conducted at the Chest Department at the Beni-Suef University Hospital after the study protocol was approved by the Research Ethics Committee of the Faculty of Medicine, Beni-Suef University (FMBSUREC\/07042024\/Hassan). It was also approved by the Research Ethics Committee of the Faculty of Pharmacy, Beni-Suef University (REC-H-PhBSU-22018) and adhered to the Declaration of Helsinki.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Each patient provided consent before participating in the study.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}